Skip to content
TrialScanner

NCT01155362

PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

Phase 2CompletedCELULeadBMYCollaborator

Registry record

Lead sponsor
Celularity Incorporated
Conditions
Crohn's Disease
Primary completion
Feb 2012Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT01155362 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT01155362: PDA001 for the Treatment of... | TrialScanner